MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited)
MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) Drug alert number: EL(26)A/10 Date issued: 24 February 2026 Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information. DMRC reference number: DMRC-38371734 Marketing Authorisation Holder: Rayner [...]
The post MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) appeared first on Community Pharmacy England.
Recent Comments